These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36515627)

  • 21. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
    Wang R; Zuo CL; Zhang R; Zhu LM
    World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of the application potential of serum multi-biomarker model in colorectal cancer screening.
    Xu R; Shen J; Song Y; Lu J; Liu Y; Cao Y; Wang Z; Zhang J
    Sci Rep; 2024 May; 14(1):10127. PubMed ID: 38698075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
    Nilsson O; Johansson C; Glimelius B; Persson B; Nørgaard-Pedersen B; Andrén-Sandberg A; Lindholm L
    Br J Cancer; 1992 Feb; 65(2):215-21. PubMed ID: 1739620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
    Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
    Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
    Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
    Wen Z; Huang Y; Ling Z; Chen J; Wei X; Su R; Tang Z; Wen Z; Deng Y; Hu Z
    Dis Markers; 2020; 2020():4716793. PubMed ID: 33488842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics.
    Zhang X; Qin H; Tan X; Mo Y; Li Z; Huang G; Wei Z
    World J Surg Oncol; 2023 Jul; 21(1):200. PubMed ID: 37420210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
    Wang QJ; Zhang HC; Shen XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
    [No Abstract]   [Full Text] [Related]  

  • 32. A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer.
    Kim BC; Joo J; Chang HJ; Yeo HY; Yoo BC; Park B; Park JW; Sohn DK; Hong CW; Han KS
    PLoS One; 2014; 9(9):e106182. PubMed ID: 25188229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus.
    Meng M; Shi LL
    World J Diabetes; 2024 Feb; 15(2):232-239. PubMed ID: 38464372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression levels and diagnostic value of serum GDNF, CEA and CA199 in patients with colorectal carcinoma.
    Jue W; Lulu L; Yan Z; Gu S
    J Med Biochem; 2024 Apr; 43(2):250-256. PubMed ID: 38699694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.